Who are we?
“Committed to making a meaningful difference to meet diverse injectable needs across a vast range of specific requirements.”
Anthea Pharma, established in 2019 is a young, R&D focused Injectables firm, backed by the prestigious Yashoda Group. Based out of Hyderabad, India, Anthea Pharma has a world class R&D facility, and an injectable manufacturing facility, currently capable of manufacturing liquid Vials, Emulsions, PFS, Lyophilized Vials and Ampoules. Anthea Pharma envisions to manufacture for the world and be a global firm focused on injectables needs with consistent supply of highest-quality products across therapeutic segments.
Our deep relationships in the healthcare and life science segment has enabled us to secure the backing of Yashoda Group, weaving a compelling blend of Hospitals, Pharmaceuticals, and Real Estate.
“Create a Benchmark in the Field of Injectables”
Anthea mission is to become the most valued injectable pharma partner to the World Pharma fraternity by continuously researching, developing and manufacturing a wide range of injectable products that comply with the highest regulatory standards.
Parent Company – Yashoda Group of Hospitals
Yashoda Hospitals is a chain of hospitals based in Hyderabad, Telangana, India. It has branches in Somajiguda, Secunderabad, and Malakpet, with another branch coming up in Hitech City, which is expected to be one of the largest medical facilities in India and will be spread over 20 lakhs sq. ft. with a capacity of 2000 beds. All of its branches are NABH and NABL accredited.
The three multi-super specialty hospitals offer tertiary and quaternary healthcare services and the group has established itself as leader in kidney, liver, heart & lung, bone marrow and multi-organ transplants. With 62 medical specialties, 700 specialist doctors, 2400 beds and close to 10,000 employees, the group has been serving the needs of over half a million patients annually.
Dr. Abhinav Gorukanti is the CEO of Anthea Pharma Pvt. Ltd, a global CDMO injectable manufacturing firm that is well-equipped for development and commercialization of a wide range of injectable products complying with the highest regulatory standards.
As a part of the founding family of the prestigious Yashoda Group, He sets the strategic direction for organizational growth and human capital for the group, which today comprises Hospitals, Pharmaceuticals, and Real Estate and an organization with over 10,000 colleagues.
Under his astute leadership, he has steered Yashoda Hospitals to evolve as a center of clinical excellence and establish itself in the international markets as a high-quality medical care provider.
He also oversees Healthcare Technology & Innovation for the group, where he sets standards for futuristic healthcare projects that incorporate IoT, AI, Data Analytics, and Blockchain.
A Philanthropist – Driven by Humanitarian initiatives, Dr. Abhinav, plays an integral role at Yashoda Foundation, dedicated to skilling and bridging the disparity in essential living that results from differences in access to and availability of resources for the unfortunate.
CRAMS – Contract Research & Manufacturing Service
With CRAMS, we aim to position ourselves as a preferred global partner with the potential to undertake a wide range of projects.
Our dedicated contract research organization (CRO) and contract manufacturing organization (CMO) teams provide customers with fast, flexible, reliable, and competitive services.
The analytical R&D team consists of scientists with expertise in areas as varied as Method Development, Method Validation, Superior Analytical Evaluation and Problem Solving Abilities.
The state-of-the-art machinery and equipment will assure fast and successful results at all stages of product development.
Our capability spans over the development of different products such as terminally sterilized, aseptically prepared and lyophilized drugs. Our key focus is to develop injectable dosages which meet the global regulatory requirements.
All the regulatory work is handled by a team exclusively dedicated to injectable manufacturing. Our well versed regulatory team supports in multiple areas.